Ahmed Naveed, Yousafzai Mohammad Tahir, Naz Qamar Farah
Department of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.
Open Forum Infect Dis. 2024 Mar 25;11(Suppl 1):S113-S120. doi: 10.1093/ofid/ofad651. eCollection 2024 Mar.
The Enterics for Global Health (EFGH) surveillance study is a longitudinal multicountry study that aims to estimate incidence rates and document consequences of diarrhea within 7 countries in Africa, Asia, and Latin America. In addition to a high incidence of childhood diarrhea, Pakistan is facing a problem of antimicrobial resistance in urban and peri-urban areas of Karachi.
In Pakistan, EFGH will be conducted in Karachi, which is one of the metropolitan cities bordering the Arabian Sea and has a diverse population of 1.6 million according to the 2017 population census. The study aims to enroll 1400 children aged 6-35 months over 2 years (2022-2024) from 6 health care facilities (Abbasi Shaheed Hospital, Khidmat-e-Alam Medical Centre, Sindh Government Hospital Korangi 5, Sindh Government Hospital Ibrahim Hyderi, Ali Akbar Shah VPT Center, and Bhains Colony VPT Center) situated in Nazimabad and Bin-Qasim town. Moreover, population enumeration and health care utilization surveys from a defined catchment area of health facilities will be conducted to estimate the diarrhea incidence rates.
The study will provide critical data to policy-makers about the burden of and antimicrobial resistance, which is essential for planning vaccine trials.
全球健康肠道研究(EFGH)是一项纵向多国研究,旨在估计非洲、亚洲和拉丁美洲7个国家的腹泻发病率并记录腹泻的后果。除了儿童腹泻发病率高之外,巴基斯坦在卡拉奇的城市和城郊地区还面临着抗菌药物耐药性问题。
在巴基斯坦,EFGH研究将在卡拉奇开展,卡拉奇是一个毗邻阿拉伯海的大城市,根据2017年人口普查,其人口多样化,达160万。该研究旨在在两年内(2022年至2024年)从位于纳齐马巴德和本卡西姆镇的6家医疗机构(阿巴西·谢赫德医院、希德马特 - 阿拉姆医疗中心、信德省政府科兰吉5号医院、信德省政府易卜拉欣·海德里医院、阿里·阿克巴·沙阿疫苗接种中心和拜恩斯殖民地疫苗接种中心)招募1400名6至35个月大的儿童。此外,还将对医疗机构特定集水区进行人口普查和医疗保健利用情况调查,以估计腹泻发病率。
该研究将为政策制定者提供有关腹泻负担和抗菌药物耐药性的关键数据,这对于规划疫苗试验至关重要。